Abstract:Abstract Background Post-stroke depression (PSD) is one of the most common neuropsychiatric complications after stroke. Studies on the underlying mechanisms and biological markers of sex differences in PSD are of great significance, but there are still few such studies. Therefore, the main objective of this study was to investigate the association of biomarkers with PSD at 3 months after minor stroke in men and women. Methods This was a prospective multicenter cohort study that enrolled 530 patients with minor stroke (males, 415; females, 115). Demographic information and blood samples of patients were collected within 24 h of admission, and followed up at 3 months after stroke onset. PSD was defined as a depressive disorder due to another medical condition with depressive features, major depressive-like episode, or mixed-mood features according to the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V). Univariate analysis was performed using the chi-square test, Mann–Whitney U test, or t-test. Partial least-squares discriminant analysis (PLS-DA) was used to distinguish between patients with and without PSD. Factors with variable importance for projection (VIP) > 1.0 were classified as the most important factors in the model segregation. Results The PLS-DA model mainly included component 1 and component 2 for males and females. For males, the model could explain 13% and 16.9% of the variables, respectively, and 29.9% of the variables in total; the most meaningful predictors were exercise habit and fibrinogen level. For females, the model could explain 15.7% and 10.5% of the variables, respectively, and 26.2% of the variables in total; the most meaningful predictors in the model were brain-derived neurotrophic factor (BDNF), magnesium and free T3. Fibrinogen was positively correlated with the Hamilton Depression Scale-17 items (HAMD-17) score. BDNF, magnesium, and free T3 levels were negatively correlated with the HAMD-17 score. Conclusions This was a prospective cohort study. The most important markers found to be affecting PSD at 3 months were fibrinogen in males, and free T3, magnesium, and BDNF in females. Trial registration ChiCTR-ROC-17013993 .

Artificial neural network and decision tree models of post-stroke depression at 3 months after stroke in patients with BMI ≥ 24

Prediction of Poststroke Depression Based on the Outcomes of Machine Learning Algorithms

Analysis of Influencing Factors of Poststroke Depression

Development of predictive model for post-stroke depression at discharge based on decision tree algorithm: A multi-center hospital-based cohort study

Association Between Obesity and Post-stroke Anxiety in Patients with Acute Ischemic Stroke

A risk prediction model for post-stroke depression in Chinese stroke survivors based on clinical and socio-psychological features

Malnutrition and poststroke depression in patients with ischemic stroke

A Risk Prediction Model of PSD in Stroke Survivors

Nomogram for Persistent Post-Stroke Depression and Decision Curve Analysis

Screening for Post-stroke Depression at Discharge Based on Sociodemographic characteristics: Decision Tree Analysis (Preprint)

Cia_a_318857 1439..1447

Association of Cerebral Artery Stenosis With Post-stroke Depression at Discharge and 3 Months After Ischemic Stroke Onset

Psychopathological Network for Early-Onset Post-Stroke Depression Symptoms

Analysis of factors associated with depressive symptoms in stroke patients based on a national cross-sectional study

Poststroke Depression and Risk of Recurrent Stroke at 1 Year in a Chinese Cohort Study.

Development and Validation of 3-Month Major Post-Stroke Depression Prediction Nomogram After Acute Ischemic Stroke Onset

Blood biomarkers of post-stroke depression after minor stroke at three months in males and females

Higher Concentration of Adrenocorticotropic Hormone Predicts Post-Stroke Depression

Nomogram including indirect bilirubin for the prediction of post-stroke depression at 3 months after mild acute ischemic stroke onset

Risk Factors for Post-Stroke Depression Following the Lifting of COVID-19 Restrictions

Predicting new-onset post-stroke depression from real-world data using machine learning algorithm